Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Hyaluronidase-4 is produced by mast cells and can cleave serglycin chondroitin sulfate chains into lower molecular weight forms.

Farrugia BL, Mizumoto S, Lord MS, O'Grady RL, Kuchel RP, Yamada S, Whitelock JM.

J Biol Chem. 2019 Jul 26;294(30):11458-11472. doi: 10.1074/jbc.RA119.008647. Epub 2019 Jun 7.

PMID:
31175155
2.

Compositional analysis of the glycosaminoglycan family in velvet antlers of Sika deer (Cervus nippon) at different growing stages.

Takeda-Okuda N, Mizumoto S, Zhang Z, Kim SK, Lee CH, Jeon BT, Hosaka YZ, Kadomatsu K, Yamada S, Tamura JI.

Glycoconj J. 2019 Apr;36(2):127-139. doi: 10.1007/s10719-019-09859-1. Epub 2019 Jan 24.

PMID:
30680582
3.

Structural alteration of glycosaminoglycan side chains and spatial disorganization of collagen networks in the skin of patients with mcEDS-CHST14.

Hirose T, Takahashi N, Tangkawattana P, Minaguchi J, Mizumoto S, Yamada S, Miyake N, Hayashi S, Hatamochi A, Nakayama J, Yamaguchi T, Hashimoto A, Nomura Y, Takehana K, Kosho T, Watanabe T.

Biochim Biophys Acta Gen Subj. 2019 Mar;1863(3):623-631. doi: 10.1016/j.bbagen.2018.12.006. Epub 2018 Dec 13.

PMID:
30553867
4.

Identification of novel LFNG mutations in spondylocostal dysostosis.

Otomo N, Mizumoto S, Lu HF, Takeda K, Campos-Xavier B, Mittaz-Crettol L, Guo L, Takikawa K, Nakamura M, Yamada S, Matsumoto M, Watanabe K, Ikegawa S.

J Hum Genet. 2019 Mar;64(3):261-264. doi: 10.1038/s10038-018-0548-2. Epub 2018 Dec 10.

PMID:
30531807
5.

Screening of known disease genes in congenital scoliosis.

Takeda K, Kou I, Mizumoto S, Yamada S, Kawakami N, Nakajima M, Otomo N, Ogura Y, Miyake N, Matsumoto N, Kotani T, Sudo H, Yonezawa I, Uno K, Taneichi H, Watanabe K, Shigematsu H, Sugawara R, Taniguchi Y, Minami S, Nakamura M, Matsumoto M; Japan Early Onset Scoliosis Research Group, Watanabe K, Ikegawa S.

Mol Genet Genomic Med. 2018 Nov;6(6):966-974. doi: 10.1002/mgg3.466. Epub 2018 Sep 9.

6.

Malonylation of histone H2A at lysine 119 inhibits Bub1-dependent H2A phosphorylation and chromosomal localization of shugoshin proteins.

Ishiguro T, Tanabe K, Kobayashi Y, Mizumoto S, Kanai M, Kawashima SA.

Sci Rep. 2018 May 16;8(1):7671. doi: 10.1038/s41598-018-26114-z.

7.

[Proteoglycan linkeropathies caused by defect in glycosaminoglycan-protein linker region].

Mizumoto S.

Seikagaku. 2017 Apr;89(2):259-63. Review. Japanese. No abstract available.

PMID:
29624993
8.

Impaired proteoglycan glycosylation, elevated TGF-β signaling, and abnormal osteoblast differentiation as the basis for bone fragility in a mouse model for gerodermia osteodysplastica.

Chan WL, Steiner M, Witkos T, Egerer J, Busse B, Mizumoto S, Pestka JM, Zhang H, Hausser I, Khayal LA, Ott CE, Kolanczyk M, Willie B, Schinke T, Paganini C, Rossi A, Sugahara K, Amling M, Knaus P, Chan D, Lowe M, Mundlos S, Kornak U.

PLoS Genet. 2018 Mar 21;14(3):e1007242. doi: 10.1371/journal.pgen.1007242. eCollection 2018 Mar.

9.

Chondroitin sulfate protects vascular endothelial cells from toxicities of extracellular histones.

Nagano F, Mizuno T, Mizumoto S, Yoshioka K, Takahashi K, Tsuboi N, Maruyama S, Yamada S, Nagamatsu T.

Eur J Pharmacol. 2018 May 5;826:48-55. doi: 10.1016/j.ejphar.2018.02.043. Epub 2018 Mar 6.

PMID:
29501579
10.

Roles of two types of heparan sulfate clusters in Wnt distribution and signaling in Xenopus.

Mii Y, Yamamoto T, Takada R, Mizumoto S, Matsuyama M, Yamada S, Takada S, Taira M.

Nat Commun. 2017 Dec 7;8(1):1973. doi: 10.1038/s41467-017-02076-0.

11.

Vascular abnormalities in the placenta of Chst14-/- fetuses: implications in the pathophysiology of perinatal lethality of the murine model and vascular lesions in human CHST14/D4ST1 deficiency.

Yoshizawa T, Mizumoto S, Takahashi Y, Shimada S, Sugahara K, Nakayama J, Takeda S, Nomura Y, Nitahara-Kasahara Y, Okada T, Matsumoto K, Yamada S, Kosho T.

Glycobiology. 2018 Feb 1;28(2):80-89. doi: 10.1093/glycob/cwx099.

12.

The reduction of heparan sulphate in the glomerular basement membrane does not augment urinary albumin excretion.

Aoki S, Saito-Hakoda A, Yoshikawa T, Shimizu K, Kisu K, Suzuki S, Takagi K, Mizumoto S, Yamada S, van Kuppevelt TH, Yokoyama A, Matsusaka T, Sato H, Ito S, Sugawara A.

Nephrol Dial Transplant. 2018 Jan 1;33(1):26-33. doi: 10.1093/ndt/gfx218.

PMID:
28992095
13.

Pathophysiological Significance of Dermatan Sulfate Proteoglycans Revealed by Human Genetic Disorders.

Mizumoto S, Kosho T, Yamada S, Sugahara K.

Pharmaceuticals (Basel). 2017 Mar 27;10(2). pii: E34. doi: 10.3390/ph10020034. Review.

14.

Identification of biallelic EXTL3 mutations in a novel type of spondylo-epi-metaphyseal dysplasia.

Guo L, Elcioglu NH, Mizumoto S, Wang Z, Noyan B, Albayrak HM, Yamada S, Matsumoto N, Miyake N, Nishimura G, Ikegawa S.

J Hum Genet. 2017 Aug;62(8):797-801. doi: 10.1038/jhg.2017.38. Epub 2017 Mar 23.

15.

Defect in dermatan sulfate in urine of patients with Ehlers-Danlos syndrome caused by a CHST14/D4ST1 deficiency.

Mizumoto S, Kosho T, Hatamochi A, Honda T, Yamaguchi T, Okamoto N, Miyake N, Yamada S, Sugahara K.

Clin Biochem. 2017 Aug;50(12):670-677. doi: 10.1016/j.clinbiochem.2017.02.018. Epub 2017 Feb 24.

16.

Functional validation of novel compound heterozygous variants in B3GAT3 resulting in severe osteopenia and fractures: expanding the disease phenotype.

Job F, Mizumoto S, Smith L, Couser N, Brazil A, Saal H, Patterson M, Gibson MI, Soden S, Miller N, Thiffault I, Saunders C, Yamada S, Hoffmann K, Sugahara K, Farrow E.

BMC Med Genet. 2016 Nov 21;17(1):86.

17.

Chondroitin Sulfate N-acetylgalactosaminyltransferase-1 (CSGalNAcT-1) Deficiency Results in a Mild Skeletal Dysplasia and Joint Laxity.

Vodopiutz J, Mizumoto S, Lausch E, Rossi A, Unger S, Janocha N, Costantini R, Seidl R, Greber-Platzer S, Yamada S, Müller T, Jilma B, Ganger R, Superti-Furga A, Ikegawa S, Sugahara K, Janecke AR.

Hum Mutat. 2017 Jan;38(1):34-38. doi: 10.1002/humu.23070. Epub 2016 Sep 22.

PMID:
27599773
18.

Pivotal Role of Carbohydrate Sulfotransferase 15 in Fibrosis and Mucosal Healing in Mouse Colitis.

Suzuki K, Arumugam S, Yokoyama J, Kawauchi Y, Honda Y, Sato H, Aoyagi Y, Terai S, Okazaki K, Suzuki Y, Mizumoto S, Sugahara K, Atreya R, Neurath MF, Watanabe K, Hashiguchi T, Yoneyama H, Asakura H.

PLoS One. 2016 Jul 13;11(7):e0158967. doi: 10.1371/journal.pone.0158967. eCollection 2016.

19.

Mutations in Biosynthetic Enzymes for the Protein Linker Region of Chondroitin/Dermatan/Heparan Sulfate Cause Skeletal and Skin Dysplasias.

Mizumoto S, Yamada S, Sugahara K.

Biomed Res Int. 2015;2015:861752. doi: 10.1155/2015/861752. Epub 2015 Oct 25. Review.

20.

Molecular interactions between chondroitin-dermatan sulfate and growth factors/receptors/matrix proteins.

Mizumoto S, Yamada S, Sugahara K.

Curr Opin Struct Biol. 2015 Oct;34:35-42. doi: 10.1016/j.sbi.2015.06.004. Epub 2015 Jul 9. Review.

PMID:
26164146
21.

Skeletal dysplasia in a consanguineous clan from the island of Nias/Indonesia is caused by a novel mutation in B3GAT3.

Budde BS, Mizumoto S, Kogawa R, Becker C, Altmüller J, Thiele H, Rüschendorf F, Toliat MR, Kaleschke G, Hämmerle JM, Höhne W, Sugahara K, Nürnberg P, Kennerknecht I.

Hum Genet. 2015 Jul;134(7):691-704. doi: 10.1007/s00439-015-1549-2. Epub 2015 Apr 19.

PMID:
25893793
22.

Receptor protein tyrosine phosphatase beta/zeta is a functional binding partner for vascular endothelial growth factor.

Koutsioumpa M, Poimenidi E, Pantazaka E, Theodoropoulou C, Skoura A, Megalooikonomou V, Kieffer N, Courty J, Mizumoto S, Sugahara K, Papadimitriou E.

Mol Cancer. 2015 Feb 3;14:19. doi: 10.1186/s12943-015-0287-3.

23.

Sulfation patterns of exogenous chondroitin sulfate affect chondrogenic differentiation of ATDC5 cells.

Kawamura D, Funakoshi T, Mizumoto S, Sugahara K, Iwasaki N.

J Orthop Sci. 2014 Nov;19(6):1028-35. doi: 10.1007/s00776-014-0643-y. Epub 2014 Sep 11.

24.

Human genetic disorders and knockout mice deficient in glycosaminoglycan.

Mizumoto S, Yamada S, Sugahara K.

Biomed Res Int. 2014;2014:495764. doi: 10.1155/2014/495764. Epub 2014 Jul 13. Review.

25.

Proteoglycans and glycosaminoglycans improve toughness of biocompatible double network hydrogels.

Zhao Y, Nakajima T, Yang JJ, Kurokawa T, Liu J, Lu J, Mizumoto S, Sugahara K, Kitamura N, Yasuda K, Daniels AU, Gong JP.

Adv Mater. 2014 Jan 22;26(3):436-42. doi: 10.1002/adma.201303387. Epub 2013 Oct 22.

PMID:
24431128
26.

[Response to neoadjuvant chemotherapy in breast cancer as assessed by subtype].

Konishi M, Minohata J, Mizumoto S, Kubo M, Hata T, Asukai K, Noguchi K, Takiuchi D, Hamano R, Yoshioka S, Kashiwazaki M, Miki H, Tsujie M, Yano H.

Gan To Kagaku Ryoho. 2013 Nov;40(12):1653-5. Japanese.

PMID:
24393878
27.

Effects of sesamin on the biosynthesis of chondroitin sulfate proteoglycans in human articular chondrocytes in primary culture.

Pothacharoen P, Najarus S, Settakorn J, Mizumoto S, Sugahara K, Kongtawelert P.

Glycoconj J. 2014 Apr;31(3):221-30. doi: 10.1007/s10719-013-9514-6. Epub 2013 Dec 12.

PMID:
24338203
28.

De novo mutations in SLC35A2 encoding a UDP-galactose transporter cause early-onset epileptic encephalopathy.

Kodera H, Nakamura K, Osaka H, Maegaki Y, Haginoya K, Mizumoto S, Kato M, Okamoto N, Iai M, Kondo Y, Nishiyama K, Tsurusaki Y, Nakashima M, Miyake N, Hayasaka K, Sugahara K, Yuasa I, Wada Y, Matsumoto N, Saitsu H.

Hum Mutat. 2013 Dec;34(12):1708-14. doi: 10.1002/humu.22446. Epub 2013 Oct 15.

PMID:
24115232
29.

Clinical and radiographic features of the autosomal recessive form of brachyolmia caused by PAPSS2 mutations.

Iida A, Simsek-Kiper PÖ, Mizumoto S, Hoshino T, Elcioglu N, Horemuzova E, Geiberger S, Yesil G, Kayserili H, Utine GE, Boduroglu K, Watanabe S, Ohashi H, Alanay Y, Sugahara K, Nishimura G, Ikegawa S.

Hum Mutat. 2013 Oct;34(10):1381-6. doi: 10.1002/humu.22377. Epub 2013 Jul 26.

PMID:
23824674
30.

Loss of dermatan sulfate epimerase (DSE) function results in musculocontractural Ehlers-Danlos syndrome.

Müller T, Mizumoto S, Suresh I, Komatsu Y, Vodopiutz J, Dundar M, Straub V, Lingenhel A, Melmer A, Lechner S, Zschocke J, Sugahara K, Janecke AR.

Hum Mol Genet. 2013 Sep 15;22(18):3761-72. doi: 10.1093/hmg/ddt227. Epub 2013 May 23.

PMID:
23704329
31.

Mutations in B3GALT6, which encodes a glycosaminoglycan linker region enzyme, cause a spectrum of skeletal and connective tissue disorders.

Nakajima M, Mizumoto S, Miyake N, Kogawa R, Iida A, Ito H, Kitoh H, Hirayama A, Mitsubuchi H, Miyazaki O, Kosaki R, Horikawa R, Lai A, Mendoza-Londono R, Dupuis L, Chitayat D, Howard A, Leal GF, Cavalcanti D, Tsurusaki Y, Saitsu H, Watanabe S, Lausch E, Unger S, Bonafé L, Ohashi H, Superti-Furga A, Matsumoto N, Sugahara K, Nishimura G, Ikegawa S.

Am J Hum Genet. 2013 Jun 6;92(6):927-34. doi: 10.1016/j.ajhg.2013.04.003. Epub 2013 May 9.

32.

Expression of N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase involved in chondroitin sulfate synthesis is responsible for pulmonary metastasis.

Mizumoto S, Watanabe M, Yamada S, Sugahara K.

Biomed Res Int. 2013;2013:656319. doi: 10.1155/2013/656319. Epub 2013 Feb 20.

33.

Human genetic disorders caused by mutations in genes encoding biosynthetic enzymes for sulfated glycosaminoglycans.

Mizumoto S, Ikegawa S, Sugahara K.

J Biol Chem. 2013 Apr 19;288(16):10953-61. doi: 10.1074/jbc.R112.437038. Epub 2013 Mar 1. Review.

34.

Glycosaminoglycans are functional ligands for receptor for advanced glycation end-products in tumors.

Mizumoto S, Sugahara K.

FEBS J. 2013 May;280(10):2462-70. doi: 10.1111/febs.12156. Epub 2013 Feb 24. Review.

35.

Interaction of chondroitin sulfate and dermatan sulfate from various biological sources with heparin-binding growth factors and cytokines.

Mizumoto S, Fongmoon D, Sugahara K.

Glycoconj J. 2013 Aug;30(6):619-32. doi: 10.1007/s10719-012-9463-5. Epub 2012 Dec 29.

PMID:
23275130
36.

[A resected case of signet-ring cell carcinoma of the rectum].

Asukai K, Yoshioka S, Hata T, Mizumoto S, Noguchi K, Takiuchi D, Hamano R, Kashiwazaki M, Miki H, Tsujie M, Konishi M, Yano K.

Gan To Kagaku Ryoho. 2012 Nov;39(12):2283-5. Japanese.

PMID:
23268051
37.

[A case of severe subcutaneous emphysema during laparoscopic right-hemicolectomy].

Kubo M, Yoshioka S, Tsujie M, Asukai K, Hata T, Mizumoto S, Noguchi K, Takiuchi D, Hamano R, Kashiwazaki M, Miki H, Konishi M, Yano H.

Gan To Kagaku Ryoho. 2012 Nov;39(12):2216-8. Japanese.

PMID:
23268028
38.

[Three cases of sigmoid colon cancer accompanied by invagination].

Yoshioka S, Asukai K, Hata T, Mizumoto S, Noguchi K, Takiuchi D, Hamano R, Kashiwazaki M, Miki H, Tsujie M, Konishi M, Yano H.

Gan To Kagaku Ryoho. 2012 Nov;39(12):2210-2. Japanese.

PMID:
23268026
39.

[Two long-term survival cases of Stage IV colon cancer through multidisciplinary treatment].

Hata T, Yoshioka S, Asukai K, Mizumoto S, Noguchi K, Takiuchi D, Hamano R, Kashiwazaki M, Miki H, Tsujie M, Konishi M, Yano H.

Gan To Kagaku Ryoho. 2012 Nov;39(12):2207-9. Japanese.

PMID:
23268025
40.

Identification of amino acid residues required for the substrate specificity of human and mouse chondroitin sulfate hydrolase (conventional hyaluronidase-4).

Kaneiwa T, Miyazaki A, Kogawa R, Mizumoto S, Sugahara K, Yamada S.

J Biol Chem. 2012 Dec 7;287(50):42119-28. doi: 10.1074/jbc.M112.360693. Epub 2012 Oct 19.

41.

Highly sulfated hexasaccharide sequences isolated from chondroitin sulfate of shark fin cartilage: insights into the sugar sequences with bioactivities.

Mizumoto S, Murakoshi S, Kalayanamitra K, Deepa SS, Fukui S, Kongtawelert P, Yamada S, Sugahara K.

Glycobiology. 2013 Feb;23(2):155-68. doi: 10.1093/glycob/cws137. Epub 2012 Sep 26.

PMID:
23019154
42.

Health status of ayahuasca users.

Barbosa PC, Mizumoto S, Bogenschutz MP, Strassman RJ.

Drug Test Anal. 2012 Jul-Aug;4(7-8):601-9. doi: 10.1002/dta.1383. Epub 2012 Jul 4. Review.

PMID:
22761152
43.

ISCSM2011 chondroitin sulfate E-type structure at tumor cell surface is involved in experimental metastasis.

Sugahara K, Mizumoto S.

Adv Exp Med Biol. 2012;749:33-45. doi: 10.1007/978-1-4614-3381-1_3. Review. No abstract available.

PMID:
22695836
45.

Glycosaminoglycan chain analysis and characterization (glycosylation/epimerization).

Mizumoto S, Sugahara K.

Methods Mol Biol. 2012;836:99-115. doi: 10.1007/978-1-61779-498-8_7.

PMID:
22252630
46.

Hyaluronidases Have Strong Hydrolytic Activity toward Chondroitin 4-Sulfate Comparable to that for Hyaluronan.

Honda T, Kaneiwa T, Mizumoto S, Sugahara K, Yamada S.

Biomolecules. 2012 Nov 12;2(4):549-63. doi: 10.3390/biom2040549.

47.

[Two cases of recurrence at anastomosis site with leakage after operation for rectal cancer].

Yoshioka S, Tsujie M, Asukai K, Hata T, Nakanishi M, Mizumoto S, Hamano R, Maekawa T, Hama N, Kashiwazaki M, Taniguchi M, Konishi M, Yano H.

Gan To Kagaku Ryoho. 2011 Nov;38(12):2316-8. Japanese.

PMID:
22202367
48.

[Two cases of ovarian metastasis of colon cancer].

Hata T, Yoshioka S, Asukai K, Mizumoto S, Nakanishi M, Hamano R, Maekawa T, Hama N, Kashiwazaki M, Taniguchi M, Tsujie M, Konishi M, Yano H.

Gan To Kagaku Ryoho. 2011 Nov;38(12):2286-8. Japanese.

PMID:
22202357
49.

[A case of refractory pancreatic fistula following pancreaticoduodenectomy treated successfully by intestinal decompression catheter insertion to jejunum under local anesthesia].

Hama N, Kashiwazaki M, Asukai K, Hata T, Mizumoto S, Nakanishi M, Hamano R, Maekawa T, Yoshioka S, Taniguchi M, Tsujie M, Konishi M, Yano H.

Gan To Kagaku Ryoho. 2011 Nov;38(12):2027-9. Japanese.

PMID:
22202273
50.

A response to: loss of dermatan-4-sulfotransferase 1 (D4ST1/CHST14) function represents the first dermatan sulfate biosynthesis defect, "dermatan sulfate-deficient Adducted Thumb-Clubfoot Syndrome". Which name is appropriate, "Adducted Thumb-Clubfoot Syndrome" or "Ehlers-Danlos syndrome"?

Kosho T, Miyake N, Mizumoto S, Hatamochi A, Fukushima Y, Yamada S, Sugahara K, Matsumoto N.

Hum Mutat. 2011 Dec;32(12):1507-9. doi: 10.1002/humu.21586. Epub 2011 Sep 30. No abstract available.

PMID:
21964831

Supplemental Content

Loading ...
Support Center